| Patients | Vaccinated patients | Vaccination rate | P-value |
---|---|---|---|---|
 | (N = 1328) | (N = 921) |  |  |
 | n/N (%) | n/N (%) |  |  |
Age, mean (SD) | 27.65(12.26) | 26.76(11.13) | NAa | Â |
Age group |  |  |  | < 0.001 |
12-17y | 230(17.3%) | 147(16.0%) | 147/230(63.9%) | Â |
18-34y | 780(58.7%) | 582(63.2%) | 582/780(74.6%) | Â |
35-49y | 228(17.2%) | 147(16.0%) | 147/228(64.5%) | Â |
50-64y | 76(5.7%) | 41(4.4%) | 41/76(53.9%) | Â |
≥ 65y | 14(1.1%) | 4(0.4%) | 4/14(28.6%) |  |
Gender | Â | Â | Â | 0.006 |
Male | 452(34.0%) | 291(31.6%) | 291/452(64.4%) | Â |
Female | 876(66.0%) | 630(68.4%) | 630/876(71.9%) | Â |
Marital status | Â | Â | Â | 0.009 |
Unmarried | 885(66.6%) | 630(68.4%) | 630/885(71.2%) | Â |
Married | 394(29.7%) | 263(28.6%) | 263/394(66.7%) | Â |
Divorce | 47(3.5%) | 27(2.9%) | 27/47(57.4%) | Â |
Unfilled | 2(0.2%) | 1(0.1%) | 1/2(50.0%) | Â |
Fertility | Â | Â | Â | 0.019 |
Already birth | 397(29.9%) | 257(27.9%) | 257/397(64.7%) | Â |
Not yet birth | 929(69.9%) | 662(71.9%) | 662/929(71.3%) | Â |
Unfilled | 2(0.2%) | 2(0.2%) | 2/2(100.0%) | Â |
Urban and rural resource |  |  |  | < 0.001 |
City | 546(41.1%) | 409(44.4%) | 409/546(74.9%) | Â |
Town | 322(24.2%) | 229(24.8%) | 229/322(71.1%) | Â |
Countryside | 457(34.4%) | 281(30.5%) | 281/457(61.5%) | Â |
Unfilled | 3(0.2%) | 3(0.3%) | 2/3(66.7%) | Â |
Education level |  |  |  | < 0.001 |
Primary school and below | 36(2.7%) | 18(1.9%) | 18/36(50.0%) | Â |
junior middle school | 240(18.1%) | 137(14.9%) | 137/240(57.1%) | Â |
College or vocational school | 405(30.5%) | 264(28.7%) | 264/405(65.2%) | Â |
Bachelor degree or above | 639(48.1%) | 497(54.0%) | 497/639(77.8%) | Â |
Unfilled | 8(0.6%) | 5(0.5%) | 5/8(62.5%) | Â |
Occupation | Â | Â | Â | 0.001 |
Employed | 604(45.5%) | 388(42.1%) | 388/604(64.2%) | Â |
Unemployed | 262(19.7%) | 189(20.5%) | 189/262(72.1%) | Â |
Student | 460(34.6%) | 342(37.1%) | 342/460(74.3%) | Â |
Unfilled | 2(0.2%) | 2(0.2%) | 2/2(100.0%) | Â |
Family income | Â | Â | Â | 0.110 |
Less than $296.77 per month | 177(13.3%) | 110(11.9%) | 110/177(62.1%) | Â |
$ 296.77-741.93 per month | 38(2.9%) | 25(2.7%) | 25/38(65.8%) | Â |
$ 741.93-1483.86 per month | 392(29.5%) | 280(30.4%) | 280/392(71.4%) | Â |
$ 1483.86-2967.71 per month | 258(19.4%) | 182(19.8%) | 182/258(70.5%) | Â |
More than $ 2967.71 per month | 162(12.2%) | 121(13.1%) | 121/162(74.7%) | Â |
Unfilled | 301(22.7%) | 203(22.1%) | 203/301(67.4%) | Â |
Psychiatric diagnosis | Â | Â | Â | 0.022 |
Bipolar disorder | 297(22.4%) | 220(23.9%) | 220/297(74.1%) | Â |
Depression disorder | 410(30.9%) | 303(32.9%) | 303/410(73.9%) | Â |
Anxiety disorder | 154(11.6%) | 102(11.1%) | 102/154(66.2%) | Â |
Obsessive-compulsory disorder | 33(2.5%) | 28(3.0%) | 28/33(84.8%) | Â |
Sleep disorder | 69(5.2%) | 55(6.0%) | 55/69(79.7%) | Â |
Schizophrenia | 177(13.3%) | 91(9.9%) | 91/177(51.4%) | Â |
Other psychiatric disorders | 188(14.2%) | 122(13.2%) | 122/188(64.9%) | Â |
Numbers of psychiatric disease | Â | Â | Â | Â |
One | 929(70.0%) | 651(70.7%) | 651/929(70.1%) | 0.072 |
Two | 267(20.1%) | 190(20.6%) | 190/267 (71.2%) | Â |
Three and above | 132(9.9%) | 80(86.7%) | 80/132(60.6%) | Â |
Somatic disease | Â | Â | Â | 0.470 |
Cardiovascular disease | 54(4.1%) | 32(3.5%) | 32/54(59.3%) | Â |
Endocrine disease | 31(2.3%) | 15(1.6%) | 15/31(48.4%) | Â |
Respiratory disease | 11(0.8%) | 6(0.6%) | 6/11(54.5%) | Â |
Tumor | 8(0.6%) | 3(0.3%) | 3/8(37.5%) | Â |
Others | 94(7.0%) | 59(6.4%) | 59/94(62.8%) | Â |
None | 1130(85%) | 806(87.5%) | 806/1130(71.3%) | Â |
Patient type |  |  |  | < 0.001 |
inpatient | 222(16.7%) | 117(12.7%) | 117/222(52.7%) | Â |
outpatient | 1060(79.8%) | 786(85.3%) | 786/1060(74.2%) | Â |
unfilled | 46(3.5%) | 18(2.0%) | 18/46(39.1%) | Â |
Intention of vaccination |  |  |  | < 0.001 |
willing | 1135(85.5%) | 880(95.5%) | 880/1135(77.5%) | Â |
unwilling | 48(3.6%) | 10(1.1%) | 10/48(20.8%) | Â |
Not sure | 64(4.8%) | 8(0.9%) | 8/64(12.5%) | Â |
Indifferent | 44(3.3%) | 19(2.1%) | 19/44(43.2%) | Â |
Unfilled | 37(2.8%) | 4(0.4%) | 4/37(10.8%) | Â |
Preferred vaccine |  |  |  | < 0.001 |
Adenovirus-vectored vaccine (one dose) | 123(9.3%) | 77(8.4%) | 77/123(62.6%) | Â |
Inactivated vaccine (two doses) | 512(38.6%) | 417(45.3%) | 417/512(81.4%) | Â |
Recombinant protein vaccine (three doses) | 173(13.0%) | 135(14.6%) | 135/173(78.0%) | Â |
Unknow | 520(39.1%) | 292(31.7%) | 292/520(56.2%) | Â |
PHQ-9b | Â | Â | Â | 0.582 |
No depression | 384(28.9%) | 269(29.2%) | 269/384(70.1%) | Â |
Mild depression | 228(17.2%) | 168(18.2%) | 168/228(73.7%) | Â |
Moderate depression | 198(14.9%) | 148(16.1%) | 148/198(74.7%) | Â |
Severe depression | 396(29.8%) | 291(31.6%) | 291/1328(73.5%) | Â |
Unfilled | 122(9.2%) | 45(4.9%) | 45/122(36.9%) | Â |
Mean (SD) | 10.42(8.18) | 10.56(8.16) | NAa | Â |
GAD-7c | Â | Â | Â | 0.115 |
No anxiety | 469(35.3%) | 321(34.9%) | 321/469(68.4%) | Â |
Mild anxiety | 249(18.8%) | 189(20.5%) | 189/249(75.9%) | Â |
Moderate anxiety | 207(15.6%) | 156(16.9%) | 156/207(75.4%) | Â |
Severe anxiety | 233(17.5%) | 169(18.3%) | 169/233(75.8%) | Â |
Unfilled | 170(12.8%) | 86(9.3%) | 86/170(50.1%) | Â |
Mean (SD) | 7.72(6.61) | 7.99(6.59) | NAa | Â |
Total | NAa | NAa | 921/1328(69.4%) | Â |